Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defining the Failure of Medical Therapy for Inflammatory Bowel Disease in the Era of Advanced Therapies: A Systematic Review
Monica State, Lucian Negreanu
Biomedicines (2023) Vol. 11, Iss. 2, pp. 544-544
Open Access | Times Cited: 11

Showing 11 citing articles:

Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options
Eguzkiñe Díez-Martín, Leidi Hernández-Suárez, Carmen Muñoz-Villafranca, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7062-7062
Open Access | Times Cited: 9
Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development
Tsvetelina Velikova, Metodija Sekulovski, Monika Peshevska-Sekulovska
Antibodies (2024) Vol. 13, Iss. 1, pp. 16-16
Open Access | Times Cited: 8
Trends in Mortality Due to Inflammatory Bowel Disease in the United States: A CDC WONDER Database Analysis (1999–2020)
Syed Sarmad Javaid, Suhail Akhtar, Ambreen Hafeez, et al.
Digestive Diseases and Sciences (2025)
Closed Access
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against Mycobacterium avium complex subspecies in patients with active Crohn’s disease
Jeremy Sanderson, Jeremy Aboagye, Rebecca Makinson, et al.
EBioMedicine (2025) Vol. 113, pp. 105570-105570
Open Access
Exploring the Impact of Cyanidin-3-Glucoside on Inflammatory Bowel Diseases: Investigating New Mechanisms for Emerging Interventions
Maximos Frountzas, Eva Karanikki, Orsalia Toutouza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9399-9399
Open Access | Times Cited: 11
Approach to loss of response to advanced therapies in inflammatory bowel disease
Nikil Vootukuru, Abhinav Vasudevan
World Journal of Gastroenterology (2024) Vol. 30, Iss. 22, pp. 2902-2919
Open Access | Times Cited: 2
The Roles of Flavonoids in the Treatment of Inflammatory Bowel Disease and Extraintestinal manifestations : A Review
Xu Gao, Xi Feng, Tao Hou, et al.
Food Bioscience (2024) Vol. 62, pp. 105431-105431
Closed Access | Times Cited: 2
Editorial: Novel Therapeutic Approaches in Inflammatory Bowel Diseases
Giovanni Pallio
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2466-2466
Open Access | Times Cited: 3
Long-term efficacy and survival of ustekinumab therapy in patients with inflammatory bowel disease
М. В. Шапина
Meditsinskiy sovet = Medical Council (2024), Iss. 15, pp. 166-172
Open Access
Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study
Bogdan Mateescu, Cristian Gheorghe, Anca Trifan, et al.
Journal of Gastrointestinal and Liver Diseases (2023) Vol. 32, Iss. 4, pp. 444-451
Open Access | Times Cited: 1
A Phase 1b Clinical Trial to Determine the Safety, Tolerability and Immunogenicity of the Candidate Mycobacterium Avium Complex Subspecies Vaccines ChAdOx2 HAV and MVA HAV in Patients with Active Crohn's Disease
Jeremy Sanderson, Jeremy Aboagye, Rebecca Makinson, et al.
(2023)
Closed Access
Page 1

Scroll to top